» Articles » PMID: 35763072

Effects of Sporisorium Reiliana Polysaccharides and Phoenix Dactylifera Monosaccharides on the Gut Microbiota and Serum Metabolism in Mice with Fructose-induced Hyperuricemia

Overview
Journal Arch Microbiol
Specialty Microbiology
Date 2022 Jun 28
PMID 35763072
Authors
Affiliations
Soon will be listed here.
Abstract

In recent decades, the prevalence of hyperuricemia has increased, and dietary fructose is an important risk factor for the development of this disease. This study investigated and compared the effects of Sphacelotheca reiliana polysaccharides and Phoenix dactylifera monosaccharides on a series of physiological and biochemical indicators and on the metagenomes and serum metabolites in mice with hyperuricemia caused by a high-fructose diet. S. reiliana polysaccharides inhibited uric acid biosynthesis and promoted uric acid excretion, thereby alleviating the hyperuricemia phenotype. In addition, hyperuricemia was closely related to the gut microbiota. After treatment with S. reiliana polysaccharides, the abundances of Bacteroidetes and Proteobacteria in the mouse intestines were decreased, the expression of genes involved in glycolysis/gluconeogenesis metabolic pathways and purine metabolism was downregulated, and the dysfunction of the gut microbiota was alleviated. With regard to serum metabolism, the abundance of hippuric acid, uridine, kynurenic acid, propionic acid and arachidonoyl decreased, and the abundances of serum metabolites in inflammatory pathways involved in kidney injury and gout, such as bile acid metabolism, purine metabolism and tryptophan metabolism pathways, decreased. P. dactylifera monosaccharides aggravated hyperuricemia. This research provides a valuable reference for the development of sugar applications.

Citing Articles

Fangyukangsuan granules ameliorate hyperuricemia and modulate gut microbiota in rats.

Zhang Q, Zhang J, Li X, Yin J, Jin L, Xun Z Front Immunol. 2024; 15:1362642.

PMID: 38745649 PMC: 11091346. DOI: 10.3389/fimmu.2024.1362642.


Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components.

Cheng-Yuan W, Jian-Gang D Front Nutr. 2023; 10:1186161.

PMID: 37377486 PMC: 10291132. DOI: 10.3389/fnut.2023.1186161.


Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease gut microbiota regulation.

Zheng L, Luo M, Zhou H, Chen J Front Pharmacol. 2023; 13:1068613.

PMID: 36733377 PMC: 9887141. DOI: 10.3389/fphar.2022.1068613.

References
1.
Dasilva G, Pazos M, Garcia-Egido E, Perez-Jimenez J, Torres J, Giralt M . Lipidomics to analyze the influence of diets with different EPA:DHA ratios in the progression of Metabolic Syndrome using SHROB rats as a model. Food Chem. 2016; 205:196-203. DOI: 10.1016/j.foodchem.2016.03.020. View

2.
Gai Z, Gui T, Hiller C, Kullak-Ublick G . Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice. J Biol Chem. 2015; 291(5):2397-411. PMC: 4732222. DOI: 10.1074/jbc.M115.694323. View

3.
He H, Ren X, Wang X, Shi X, Wang X, Ding Z . Therapeutic effect of Yunnan Baiyao on rheumatoid arthritis was partially due to regulating arachidonic acid metabolism in osteoblasts. J Pharm Biomed Anal. 2011; 59:130-7. DOI: 10.1016/j.jpba.2011.10.019. View

4.
Jiang S, Du P, An L, Yuan G, Sun Z . Anti-diabetic effect of Coptis Chinensis polysaccharide in high-fat diet with STZ-induced diabetic mice. Int J Biol Macromol. 2013; 55:118-22. DOI: 10.1016/j.ijbiomac.2012.12.035. View

5.
Johnson R, Bakris G, Borghi C, Chonchol M, Feldman D, Lanaspa M . Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. Am J Kidney Dis. 2018; 71(6):851-865. PMC: 7286363. DOI: 10.1053/j.ajkd.2017.12.009. View